Search research articles
Contact Us
Filters
Showing results (1-10 of 484) with videos related to
Page
of 49
Sort By:
The Journal of Urology
|
July 24, 2007
Chemoprevention of prostate cancer: agents and study designs
Ian M Thompson
BJU International
|
June 28, 2007
Chemoprevention of prostate cancer: lessons learned
Ian M Thompson
Oncology (Williston Park, N.Y.)
|
September 5, 2014
Focal therapy of prostate cancer-the challenge
Ian M Thompson
The New England Journal of Medicine
|
January 21, 2026
European Study of Prostate Cancer Screening - 23-Year Follow-up
Ian M Thompson
The Journal of Nutrition
|
September 22, 2006
PSA: a biomarker for disease. A biomarker for clinical trials. How useful is it?
Ian M Thompson
Urology
|
March 10, 2010
Editorial comment
Ian M Thompson
The Journal of Urology
|
November 7, 2006
Defining high risk prostate cancer--where do we set the bar? A translational science approach to risk stratification
Ian M Thompson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Overdiagnosis and overtreatment of prostate cancer
Ian M Thompson
Urology
|
July 27, 2010
Editorial Comment on adjuvant radiotherapy study
Ian M Thompson
Health News (Waltham, Mass.)
|
January 14, 2003
Prostate cancer: wait or treat? How to apply new findings to your individual situation
Ian M Thompson
Page
of 49
Search research articles
Search
Showing results (1-10 of 484) with videos related to
Sort By:
Page
of 49
The Journal of Urology
|
July 24, 2007
Chemoprevention of prostate cancer: agents and study designs
Ian M Thompson
BJU International
|
June 28, 2007
Chemoprevention of prostate cancer: lessons learned
Ian M Thompson
Oncology (Williston Park, N.Y.)
|
September 5, 2014
Focal therapy of prostate cancer-the challenge
Ian M Thompson
The New England Journal of Medicine
|
January 21, 2026
European Study of Prostate Cancer Screening - 23-Year Follow-up
Ian M Thompson
The Journal of Nutrition
|
September 22, 2006
PSA: a biomarker for disease. A biomarker for clinical trials. How useful is it?
Ian M Thompson
Urology
|
March 10, 2010
Editorial comment
Ian M Thompson
The Journal of Urology
|
November 7, 2006
Defining high risk prostate cancer--where do we set the bar? A translational science approach to risk stratification
Ian M Thompson
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting
|
January 24, 2014
Overdiagnosis and overtreatment of prostate cancer
Ian M Thompson
Urology
|
July 27, 2010
Editorial Comment on adjuvant radiotherapy study
Ian M Thompson
Health News (Waltham, Mass.)
|
January 14, 2003
Prostate cancer: wait or treat? How to apply new findings to your individual situation
Ian M Thompson
Page
of 49